Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 682418, 12 pages
Research Article

Inhibition of Helicobacter pylori CagA-Induced Pathogenesis by Methylantcinate B from Antrodia camphorata

1Graduate Institute of Clinical Medical Science, China Medical University, Taichung 40402, Taiwan
2Institute of Biochemical Sciences and Technology, Chaoyang University of Technology, Taichung 41349, Taiwan
3Department of Biochemistry and Molecular Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA 95817, USA
4Department of Internal Medicine, China Medical University Hospital, Taichung 40402, Taiwan
5Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 40227, Taiwan
6Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan
7Department of Microbiology and Graduate Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan

Received 11 October 2012; Accepted 23 December 2012

Academic Editor: Mohd Roslan Sulaiman

Copyright © 2013 Chun-Jung Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Yerra Koteswara Rao, Madamanchi Geethangili, and Yew-Min Tzeng, “Development of a high performance liquid chromatography method for the quantitative determination of bioactive triterpenoids in the extracts of Antrodia camphorata,” Analytical Methods, vol. 5, no. 20, pp. 5724, 2013. View at Publisher · View at Google Scholar
  • Chun-Lung Feng, Chia-Shuo Chang, Chih-Ho Lai, Chiu-Lien Hung, Chia-Han Chu, Cheng-Kuo Lai, Ying-Ju Lin, and Hong-Lin Su, “Characterization of Putative Cholesterol Recognition/Interaction Amino Acid Consensus-Like Motif of Campylobacter jejuni Cytolethal Distending Toxin C,” Plos One, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Guadalupe Ayala, Wendy Itzel Escobedo-Hinojosa, and Carlos Felipe de la Cruz-Herrera, “Exploring alternative treatments for Helicobacter pylori infection,” World Journal of Gastroenterology, vol. 20, no. 6, pp. 1450–1469, 2014. View at Publisher · View at Google Scholar
  • Min-Chuan Kao, Yerra Koteswara Rao, Yu-Wen Hsieh, Shih-Hsien Weng, Tzu-Li Lu, David T.W. Tzeng, Jau-Jin Liu, Chun-Jung Lin, Chih-Ho Lai, and Yew-Min Tzeng, “A cyclohexadepsipeptide from entomogenous fungi Metarhizium anisopliae inhibits the Helicobacter pylori induced pathogenesis through attenuation of vacuolating cytotoxin-A activity,” Process Biochemistry, 2014. View at Publisher · View at Google Scholar
  • Hwai-Jeng Lin, Fang-Yu Hsu, Wei-Wei Chen, Che-Hsin Lee, Ying-Ju Lin, Yi-Ywan M. Chen, Chih-Jung Chen, Mei-Zi Huang, Min-Chuan Kao, Yu-An Chen, Hsin-Chih Lai, and Chih-Ho Lai, “Helicobacter pylori Activates HMGB1 Expression and Recruits RAGE into Lipid Rafts to Promote Inflammation in Gastric Epithelial Cells,” Frontiers in Immunology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Ummay Mahfuza Shapla, Md. Jinat Raihan, Md. Asiful Islam, Fahmida Alam, Md. Solayman, Siew Hua Gan, Md. Sakib Hossen, and Md. Ibrahim Khalil, “Propolis: The future therapy against Helicobacter pylori -mediated gastrointestinal diseases,” Journal of Applied Biomedicine, 2017. View at Publisher · View at Google Scholar